Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.

Journal of Antibiotics

Volumn 61, Issue 6, 2008, Pages 387-393

  Igarashi, Masayuki ^a   Sawa, Ryuichi ^a   Kinoshita, Naoko ^a   Hashizume, Hideki ^a   Nakagawa, Naoko ^a   Homma, Yoshiko ^a   Nishimura, Yoshio ^a   Akamatsu, Yuzuru ^a  

^a INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

Amycolatopsis sp.; Cyclic peptide; MRSA; Pargamicin A; VRE

Indexed keywords

CYCLOPEPTIDE; PARGAMICIN A; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; PIPERAZIC ACID; PYRIDAZINE DERIVATIVE;

ACTINOBACTERIA; AMYCOLATOPSIS; ARTICLE; BACTERIAL STRAIN; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ACTINOMYCETALES; BIOSYNTHESIS; CHEMISTRY; CLASSIFICATION; CULTURE MEDIUM; DRUG EFFECT; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION;

AMYCOLATOPSIS; AMYCOLATOPSIS SP.; ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ACTINOMYCETALES; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CULTURE MEDIA, CONDITIONED; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FERMENTATION; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; PYRIDAZINES; STAPHYLOCOCCUS AUREUS;

EID: 56149083422     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.54     Document Type: Article

References (15)

1. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, Clark N, Killgore G, O'Hara CM, Jevitt L, Patel JB, Bozdogan B. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 48: 275-280 (2004)
2. Rybak MJ, Hershberger E, Moldovan T, Grucz RG. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob Agents Chemother 44: 1062-1066 (2000)
3. Shiring EB, Gottlieb D. Methods for characterization of Streptomyces species. Int J Syst Bacteriol 16: 313-340 (1966)
4. Waksman SA. Classification, identification and descriptions of genera and species. In the Actinomycetes, Vol. II, pp. 327-334, The Williams & Wilkins Co., Baltimore (1961)
5. Staneck JL, Roberts GD. Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl Microbiol 28: 226-231 (1974)
6. Lechevalier MP, Lechevalier HA. The chemotaxonomy of actinomycetes. In Actinomycete taxonomy Ed., Dietz AD et al., pp. 227-291, Society for Industrial Microbiology, Virginia (1980)
7. Collins MD, Pirouz T, Goodfellow M, Minnikin DE. Distribution of menaquinones in actinomycetes and corynebacteria. J Gen Microbiol 100: 221-230 (1977)
8. Minnikin DE, Patel PV, Alshamaony L, Goodfellow M. Polar lipid composition in the classification of Nocardia and related bacteria. Int J Syst Bacteriol 27: 104-117 (1977)
9. Minnikin DE, Hutchinson IG, Caldicott AB, Goodfellow M. Thin-layer chromatography of methanolysates of mycolic acid-containing bacteria. J Chromatography 188: 221-233 (1980)
10. Hamada M, Kinoshita N, Hattori S, Yoshida A, Okami Y, Higashide K, Sakata N, Hori M. Streptomyces kasugaensis sp. nov: A new species of genus Streptomyces. Actinomycetol 9: 27-36 (1995)
11. Kinoshita N, Igarashi M, Ikeno S, Hori M, Hamada M. Saccharothrix tangerinus sp. nov., the producer of the new antibiotic formamicin: taxonomic studies. Actinomycetol 13: 20-31 (1999)
12. Japan Society of Chemotherapy. Method of MIC determination. Chemother 29: 77-79 (1981) (in Japanese)
13. Brosius J, Palmer ML, Kennedy PJ, Noller HF. Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli. Proc Natl Acad Sci USA 75: 4801-4805 (1978)
14. Lechevalier MP, Prauser H, Labeda DP, Ruan JS. Two new genera of Nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov. Int J Syst Bacteriol 36: 29-37 (1986)
15. Pettibone DJ, Clineschmidt BV, Anderson PS, Freidinger RM, Lundell GF, Koupal LR, Schwartz CD, Williamson JM, Goetz MA, Hensens OD, et al. A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis. Endocrinology 125: 217-222 (1989)